基于模型的配方开发: Bridging Experimental Data and Mechanistic Modeling

日期 2025 年 6 月 10 日

时间 11am ET

概述

Predictive modeling is driving innovation in both novel and generic drug development, offering a faster, more efficient path to approval. By leveraging model-informed formulation development (MIFD), you can make data-driven decisions to:

Optimize early-stage formulation development
Forecast food and formulation effect
Establish virtual bioequivalence
Support bridging studies and biowaiver strategies
Reliably determine clinical safe space

In this webinar, leading biopharmaceutics experts will explore the latest trends in biopharmaceutics development and demonstrate specialized solutions designed to inform and accelerate the formulation development process.

点击报名

Key topics include:

Trends in Biopharmaceutics Development: Biopharmaceutics experts highlight the growth of Model-informed formulation development and key applications such as food effect, potential pH-related drug-drug interactions, and virtual bioequivalence (VBE).
Strategic Partnership with Biowaived: Certara and Biowaived’s strategic partnership integrates assay development and data production in line with biosimulation solutions. Biowaived will discuss how it’s critical for bench scientists and modelers to work closely together to successfully address biopharmaceutics challenges.
Simcyp™ Biopharmaceutics: Certara’s biopharmaceutics software platform for small molecule drug development enhances formulation strategies, accelerates development timelines, and improves biowaiver success rates. Our experts will provide an overview of Simcyp Biopharmaceutics and highlight key software updates.

Join us for an engaging discussion on how predictive modeling and integrated biopharmaceutics solutions are reshaping the future of drug development and approval.